CYBB and acute myeloid leukemia: In addition, pharmacological inhibition of NOX2 using histamine dihydrochloride, which is used in conjunction with low‐dose interleukin‐2 for relapse prevention in the postchemotherapy phase of AML 14, reduced the expansion of xenografted human AML cells in vivo in a NOX2‐dependent manner 15.